Bring names rather than guesses
Write down the medicines and supplements you use. Bring the names from their labels if you can.
Include past reactions and what happened at the time. Ask the clinician which details matter for the options being discussed.
There is no official avoidance list to rely on
BPC-157 had no official medicine instructions and warnings reviewed by FDA at the September 28, 2026 check.
Medicine review is handled by FDA, a US agency. It has not reviewed a list of who must avoid BPC-157 or how it may affect other medicines.
An interaction is when substances affect one another. A missing list is a gap in information, not reassurance that nothing could happen.
Bring pregnancy questions into the discussion
The human studies in FDA's review did not study pregnancy, and there is no FDA-reviewed pregnancy information for BPC-157.
Include any current pregnancy, plans to become pregnant or breastfeeding in the discussion. Ask how the missing information affects the choices.
Ask for an answer about your situation
Ask the clinician to explain which parts of your history affect the assessment. Ask what they still need to find out.
If the reply is only a general sales claim, return to the personal question. How does that claim apply to the problem and history you brought?